Impact of screening for breast cancer in high-risk women on health-related quality of life
- PMID: 15199386
- PMCID: PMC2364757
- DOI: 10.1038/sj.bjc.6601912
Impact of screening for breast cancer in high-risk women on health-related quality of life
Abstract
The effectiveness of intensive surveillance in women at high risk for breast cancer due to a familial or genetic predisposition is uncertain and is currently being evaluated in a Dutch magnetic resonance imaging (MRI) screening (MRISC) study, in which annual imaging consists of mammography and MRI. Unfavourable side effects on health-related quality of life may arise from this screening process. We examined the short-term effects of screening for breast cancer in high-risk women on generic health-related quality of life and distress. A total of 519 participants in the MRISC study were asked to complete generic health-status questionnaires (SF-36, EQ-5D) as well as additional questionnaires for distress and items relating to breast cancer screening, at three different time points around screening. The study population showed significantly better generic health-related quality of life scores compared to age-/sex-adjusted reference scores from the general population. Neither generic health-related quality of life scores nor distress scores among the study sample (n=334) showed significant changes over time. The impact of the screening process on generic health status did not differ between risk categories. Relatively more women reported mammography as quite to very painful (30.1%) compared to MRI. Anxiety was experienced by 37% of the women undergoing MRI. We conclude that screening for breast cancer in high-risk women does not have an unfavourable impact on short-term generic health-related quality of life and general distress. In this study, high-risk women who opted for regular breast cancer screening had a better health status than women from the general population.
Figures
References
-
- Aaronson NK, Acquadro C, Alonso J, Apolone G, Bucquet D, Bullinger M (1992) International Quality of Life Assessment (IQOLA) Project. Qual Life Res 1: 349–351 - PubMed
-
- Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51: 1055–1068 - PubMed
-
- Arrindell WA, Ettema JHM (1986) SCL-90: Manual at A Multidimensional Psychopathology-Indicator [in Dutch]. University of Groningen, Department of Clinical Psychology, Groningen, The Netherlands
-
- Brekelmans CTM, Seynaeve C, Bartels CCM, Tilanus-Linthorst MMA, Meijers-Heijboer EJ, Crepin CMG, van Geel AN, Menke M, Verhoog LC, van den Ouweland A, Obdeijn IM, Klijn JGM (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19: 924–930 - PubMed
-
- Brooks R (1996) EuroQol: the current state of play. Health Policy 37: 53–72 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Medical